why choose us

First received: February 02, 2023

Clinical Trial: Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hemorrhage

Study Type: OBSERVATIONAL


Official Title: Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

Brief Summary: There is need for a whole blood analog for use when banked blood is unavailable or undesirable.In civilian trauma, hemorrhage accounts for ~ 35% of pre-hospital deaths; moreover, ~ 20% of military casualties are in hemorrhagic shock on arrival to field hospitals and an additional 5% require urgent transfusion.A recent review concluded that hemorrhage accounted for ~ 90% of potentially survivable battlefield deaths - lives that could be saved with better hemorrhage control capabilities and improved, field-ready…

Read more